certified mortality fell by 35 % for leukaemias , 90 % for hodgkin 's disease , 30 % for non-hodgkin 's lymphomas , 40 % for bone sarcomas , 30 % for kidney ( wilms ' ) tumours , 65 % for retinoblastoma .
C0022646
kidney
C0027708
wilms